Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dana Point Rehab Campus is a private, for-profit behavioral healthcare provider focused on addiction treatment and related mental health services in Dana Point, California. The organization offers supervised detox through partner facilities, residential treatment, intensive outpatient and outpatient care, counseling, and aftercare support for people with substance use and dual-diagnosis needs. Public listings describe an integrative, evidence-based treatment model that includes individual, group, and family therapy, and in some cases medication-assisted treatment such as buprenorphine, naltrexone, and Suboxone during detox or recovery support. It appears to operate as a treatment services business rather than a drug-development biotech or pharma company, with no evidence of an R&D pipeline, therapeutic product portfolio, or platform technology. The company is therefore healthcare-related, but specifically in provider services rather than life sciences innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dana Point Rehab Campus.